These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31317351)

  • 21. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.
    Newland PK; Naismith RT; Ullione M
    J Neurosci Nurs; 2009 Dec; 41(6):322-8. PubMed ID: 19998683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of self-acupressure on quality of life, physical and cognitive function in relapsing remitting multiple sclerosis patients: A randomized controlled study.
    Bilek F; Bahcecioglu-Turan G; Ozer Z
    Explore (NY); 2023; 19(1):84-90. PubMed ID: 35351367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
    Baumstarck K; Pelletier J; Butzkueven H; Fernández O; Flachenecker P; Idiman E; Stecchi S; Boucekine M; Auquier P;
    Eur J Neurol; 2013 Jun; 20(6):907-14, e78-9. PubMed ID: 23347258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study.
    D'Amico D; Grazzi L; Bussone G; Curone M; Di Fiore P; Usai S; Leonardi M; Giovannetti AM; Schiavolin S; Raggi A
    Headache; 2015 May; 55(5):636-45. PubMed ID: 25913219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis.
    van der Hiele K; van Gorp DA; Heerings MA; van Lieshout I; Jongen PJ; Reneman MF; van der Klink JJ; Vosman F; Middelkoop HA; Visser LH;
    BMC Neurol; 2015 Aug; 15():134. PubMed ID: 26264389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability.
    van Mastrigt GA; Evers SM; Heerings M; Visser LH; Ruimschotel RP; Hussaarts A; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Jongen PJ
    J Med Econ; 2019 Oct; 22(10):967-980. PubMed ID: 31084442
    [No Abstract]   [Full Text] [Related]  

  • 30. Does the relationship between physical activity and quality of life differ based on generic versus disease-targeted instruments?
    Motl RW; McAuley E; Snook EM; Gliottoni RC
    Ann Behav Med; 2008 Aug; 36(1):93-9. PubMed ID: 18719976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life and psychiatric co‑morbidity in Indian migraine patients: a headache clinic sample.
    Sharma K; Remanan R; Singh S
    Neurol India; 2013; 61(4):355-9. PubMed ID: 24005724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing an evaluation scale for the perception of quality of life related to relapsing-remitting forms of multiple sclerosis and feasibility study.
    Baroin A; Mokadym H; Chopard G; Lavier A; Berger E; Rumbach L; Rude N
    Int J Neurosci; 2012 Jan; 122(1):9-16. PubMed ID: 21848501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of quality of life in renal transplant recipients and patients with multiple sclerosis: a follow-up study.
    Fernández-Jiménez E; Pérez-San-Gregorio MA; Martín-Rodríguez A; Pérez-Bernal J; Izquierdo G
    Transplant Proc; 2013; 45(10):3616-9. PubMed ID: 24314975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
    Mikula P; Nagyova I; Krokavcova M; Vitkova M; Rosenberger J; Szilasiova J; Gdovinova Z; Groothoff JW; van Dijk JP
    Psychol Health Med; 2015; 20(6):653-61. PubMed ID: 25879302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.
    Morales-Gonzáles JM; Benito-León J; Rivera-Navarro J; Mitchell AJ;
    Mult Scler; 2004 Feb; 10(1):47-54. PubMed ID: 14760952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and health of patients in early stages of Multiple sclerosis.
    Duka Glavor K; Titlić M; Vuletic G
    Psychiatr Danub; 2019 Mar; 31(Suppl 1):118-125. PubMed ID: 30946730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):8-16. PubMed ID: 22250605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.